What Is ER-100? OSK Reprogramming and Optic Nerve Research
ER-100 is an investigational gene therapy designed to restore function in retinal ganglion cells through partial epigenetic reprogramming. Its scientific foundation is controlled expression of three transcription factors: OCT4, SOX2 and KLF4, collectively called OSK. The current clinical program concerns optic neuropathies, specifically open-angle glaucoma and non-arteritic anterior ischemic optic neuropathy, or NAION. It is not an established treatment for these conditions. [1]
What Is FOXO4-DRI? Senolytic Peptide Explained

FOXO4-DRI is a synthetic D-retro-inverso peptide studied as a tool that disrupts the FOXO4-p53 partnership linked to senescent-cell survival in published models. Identifiers include CAS 2460055-10-9, formula C228H388N86O64, about 5358 g/mol, and PubChem CID 167312269. Searchers also use FOXO4 DRI and Proxofim for the same research peptide.